While in normal adult cells macroH2A1 isoforms are expressed with similar levels, macroH2A1.1 decreases in a variety of human cancers including breast [37], colorectal [38], lung [39, 40], testis, bladder, ovarian, endometrial and cervical cancers [40]; and the ratio macroH2A1.1 / macroH2A1.2 has a profound effect on patient prognosis and survival. This evidence concerns the gene MACROH2A1 and cervical cancer.